EQT Group ac­quires VC firm in $500M+ deal; Sanofi se­lects IPO lead­ers for 2022 API spin­out — re­port

Pri­vate in­vest­ment group EQT an­nounced an agree­ment this morn­ing to buy out Life Sci­ence Part­ners, a Eu­ro­pean VC firm with more than $2.5 bil­lion un­der man­age­ment.

While de­tails are not com­plete, EQT agreed to $520 mil­lion up­front — 25% in cash and 75% in new EQT shares. There is al­so po­ten­tial for a $29 mil­lion earn-out pay­ment, ac­cord­ing to an EQT state­ment.

Michael Bauer, Part­ner and Co-Head of EQT’s Glob­al Health­care sec­tor team, said, “We are tru­ly ex­cit­ed about the op­por­tu­ni­ty to join forces with LSP and form EQT Life Sci­ences. The EQT and LSP teams have com­ple­men­tary skill sets, and the com­bi­na­tion will al­low us to sup­port health­care com­pa­nies and their man­age­ment teams in a unique way.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.